More clinical trials are conducted for cancer than for other therapeutic areas, and these trials often include participants who have exhausted the available treatment options. So when COVID-19 forced a re-assessment of ongoing and upcoming studies, patients and care providers were placed in a difficult situation. We’ll talk to a leading cancer researcher and a patient who was in screening for a new clinical trial, about the present and future of oncology clinical trials.
Our expert speakers discuss:
- How did cancer research centers react to COVID-19 and make decisions about continuing or pausing clinical trials, and what are they planning for the near future?
- What kind of long-term effects might we see in the design and conduct of oncology clinical trials as a result of COVID-19?
- The patient perspective: How it feels to get the call that your cancer clinical trial has been put on indefinite hold